Mark Kotter

Mark Kotter (born 1971) is a Canadian neurosurgeon, biologist, and entrepreneur. He is the founder and CEO of the biotechnology company bit.bio and the co-founder of the cultured meat company Meatable.

Mark Kotter
Born	Mark Reinhard Kotter Calgary, Canada
Nationality	Austrian, Canadian
Alma mater	University of Graz, University of Cambridge
Known for	cell programming, degenerative cervical myelopathy
Scientific career
Fields	Biology, Neurosciences, Medicine
Institutions	University of Cambridge, bit.bio, clock.bio, Myelopathy.org, Meatable
Website	mark-kotter.medium.com

Early life and education

Kotter was born in Canada and raised in Austria, Germany, and Australia. He studied medicine in Graz and earned a PhD in stem cell biology from the University of Cambridge. He completed postgraduate medical training in Berlin and Vienna and later worked at the Max Planck Institute.^[1]

Career

Kotter has made contributions to the importance of macrophages for brain regeneration,^[2] His work on cell programming includes the development of opti-ox (optimized inducible overexpression).^[3]

In 2016, Kotter founded it as Elpis Biomed, the company's name later changed to bit.bio to give a clearer indication of its function in cell coding: "bit" refers to the smallest building block in coding, while "bio" refers to the live cells that are being reprogrammed.^[4]

In 2019, Kotter co-founded the charity Myelopathy.org to provide information on Degenerative Cervical Myelopathy.^[5] In 2018, Kotter co-founded the cultured meat company Meatable with Daan Luining.^[6]